Cardiovascular Diseases
Kardiologie Hassloch focuses its clinical research on cardiovascular diseases, aiming to evaluate new therapies that lower major adverse cardiovascular events and improve heart function in patients with diverse risk profiles.
- Atherosclerotic cardiovascular disease
- Heart failure with preserved or mildly reduced ejection fraction and systemic inflammation
- Type 2 diabetes with cardiovascular involvement
- Hypertension
- Combined risk of diabetes, hypertension and established cardiovascular disease
Recent studies at the site test agents such as AZD0780, the vicadrostat‑empagliflozin combination, and ziltivekimab, seeking to demonstrate superiority over placebo in preventing cardiovascular death, heart‑failure hospitalizations, and major vascular events.
